BIOMAT Database Logo BIOMAT Database Logo

[Tienilic acid can induce acute hepatitis, chronic hepatitis and cirrhosis. A report of three cases (author's transl)]. 1981

E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006016 Glycolates Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon. 2-Hydroxyacetates,Glycolate Ethers,Hydroxyacetate Ethers,Hydroxyacetates,Hydroxyacetic Acids,2 Hydroxyacetates,Acids, Hydroxyacetic,Ethers, Glycolate,Ethers, Hydroxyacetate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013989 Ticrynafen A novel diuretic with uricosuric action. It has been proposed as an antihypertensive agent. Tienilic Acid,ANP-3624,SKF-62698,Selacryn,Thienylic Acid,ANP 3624,ANP3624,Acid, Thienylic,Acid, Tienilic,SKF 62698,SKF62698
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Hepatitis during treatment with tienilic acid (author's transl)].
January 1980, Therapie,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Acute renal failure after administration of tienilic acid (author's transl)].
January 1981, Therapie,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Tienilic acid and biliary secretion (author's transl)].
May 1981, Annales pharmaceutiques francaises,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Tienilic acid as a likely cause of "auto immune" active hepatitis (author's transl)].
June 1980, La Nouvelle presse medicale,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Tienilic acid-induced hepatitis associated with liver/kidney microsomal antibody (author's transl)].
June 1980, La Nouvelle presse medicale,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Acute hepatitis due to tienilic acid].
January 1981, Gastroenterologie clinique et biologique,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Hepatic necrosis secondary to tienilic acid therapy (author's transl)].
January 1980, Therapie,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Acid-base disturbance in patients with compensated liver cirrhosis and chronic hepatitis (author's transl)].
December 1981, Nihon Ika Daigaku zasshi,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Tienilic acid in the treatment of hyperuricemia syndrome (author's transl)].
December 1981, Bratislavske lekarske listy,
E A Pariente, and C André, and E S Zafrani, and J M Métreau, and D Dhumeaux, and P Berthelot
[Primary biliary cirrhosis or chronic active hepatitis. Observations on five unclassified cases (author's transl)].
December 1980, Gastroenterologie clinique et biologique,
Copied contents to your clipboard!